Developmental Pathways in CAVD
نویسندگان
چکیده
Calcific Aortic Valve Disease (CAVD) occurs in >2% of the population over 65 years of age and often leads to valvular stenosis that necessitates valve replacement [1]. CAVD is a pro‐ gressive disease, often manifesting first as aortic valve sclerosis and later developing into stenosis and valve dysfunction [2]. The specific molecular and cellular mechanisms of CAVD initiation and advancement are not well defined, and inhibitors of CAVD progres‐ sion have not been identified. The current standard of treatment for CAVD is aortic valve replacement [3]. Presently, there are no pharmacologic-based treatments for CAVD, and new therapeutic approaches for CAVD are needed. The majority of aortic valves that are re‐ placed have congenital malformations, such as bicuspid aortic valve (BAV), establishing a link between valve development and disease mechanisms [4].
منابع مشابه
MicroRNA Expression Signature in Human Calcific Aortic Valve Disease
Altered microRNA (miRNA, miR) expression has been related to many disease processes; however, the miRNA expression signature in calcific aortic valve disease (CAVD) is unclear. In this study, microarrays were used to determine the miRNA expression signature of tissue samples from healthy individuals (n = 4) and patients with CAVD (n = 4). TargetScan, PITA, and microRNAorg 3-way databases were u...
متن کاملCalcific Aortic Valve Disease: a Developmental Biology Perspective
PURPOSE OF REVIEW This review aims to highlight the past and more current literature related to the multifaceted pathogenic programs that contribute to calcific aortic valve disease (CAVD) with a focus on the contribution of developmental programs. RECENT FINDINGS Calcification of the aortic valve is an active process characterized by calcific nodule formation on the aortic surface leading to...
متن کاملCalcific Aortic Valve Disease
Despite the high prevalence and severe consequences of calcific aortic valve disease (CAVD), its pathogenesis remains relatively poorly understood. For many years, CAVD was considered a degenerative disease, where calcification was a consequence of normal aging. Although it is now widely accepted that CAVD is an active disease process, the erroneous degenerative label contributed to delayed pro...
متن کاملAdvances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets
Calcific Aortic Valve Disease (CAVD) is the most common heart valve disease and its incidence is expected to rise with aging population. No medical treatment so far has shown slowing progression of CAVD progression. Surgery remains to this day the only way to treat it. Effective drug therapy can only be achieved through a better insight into the pathogenic mechanisms underlying CAVD. The cellul...
متن کاملHealth Behaviors and Calcific Aortic Valve Disease
C alcific aortic valve disease (CAVD) is the most common form of valvular heart disease worldwide and is associated with increased mortality across the spectrum of severity of disease. The 1-year mortality rates among individuals with untreated severe symptomatic aortic stenosis nears 50%. Because of rapid population aging, global CAVD prevalence is expected to double in the next 50 years. More...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017